Sebastian Waszak

PhD

Oslo, Norway

University of Oslo

waszak.jpg

About

Group Leader

Center for Molecular Medicine Norway (NCMM), University of Oslo

My lab focuses on precision medicine for children, adolescents, and young adults with cancer; in particular children with brain tumours. We combine approaches from population genomics, cancer genomics, and systems genetics to understand the genetic basis of cancer, the somatic evolution of cancer cells, and the mechanisms that drive genome and proteome instability in cancer. We further aim to improve the diagnosis, prognosis, and therapeutic recommendations for brain cancer patients based on the development of novel computational approaches that integrate multiple layers of molecular information.

oslo norway center for molecular medicine.jpg

University of Oslo

Oslo, Norway

scientific

Projects

Asset 18.png

Data

Ongoing

Landscape of Germline Histone Mutations in Pediatric Brain Tumor Patients

Research is needed to better understand the underlying cause of diffuse midline gliomas (DMGs). Using data provided by the Children’s Brain Tumor Atlas, researchers on this project will investigate mutations affecting histones in DMGs.

DIPG

Javad Nazarian PhD.jpg

Javad Nazarian

Children’s National Hospital
Washington, DC, USA
Asset 15.png

Data

Ongoing

Using histopathology to discover genetic alterations in pediatric brain tumors

In depth understanding of the molecular make up of brain tumors is critical to inform therapy decision making. Often tumor tissue is limited for this type of analysis and it will be very beneficial to derive detail molecular information from basic pathology slides. Herein we aim to use machine learning to develop such program that will allow us to predict the molecular make up based on analysis of standard pathology slides. Funding for the project was provided by Ian’s Friends Foundation.

All Brain Tumor Types

Mueller_Sabine_2019-740x864.jpg

Sabine Mueller

UCSF Benioff Children's Hospital
San Francisco and Oakland, CA, USA
Asset 20.png

Data

Ongoing

Genetic Architecture of Molecular Phenotypes in Pediatric Brain Cancers

The identification of germline protein expression in brain cancer cells is pivotal in guiding the development of new treatments.s. Using the Pediatric Brain Tumor Atlas, researchers seek to create an important resource on the details of protein expression across many individual brain cancer types.

All Brain Tumor Types

waszak.jpg

Sebastian Waszak

University of Oslo
Oslo, Norway